Immunic Inc
Biotechnology
Healthcare
IMUX
44.43 M shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
1.49
52 week high
10.80
high
1.54
52 week low
1.32
low
1.43
growth
-5.84 %
previous Close
1.50
P/E ratio
market cap
80.81 M
div yield
0
usd
Jun 2023
qoq
revenue
0.00 %
net incoming
-24.00 M
5.04 %
eps
0.00 %
6.90 %
eps surprise
-3.85 %
net profit margin
-2399900000.00 %
0.00 %
operating incoming
-25.02 M
8.18 %
net change in cash
-15.47 M
-9.49 %
cash on hand
77.29 M
-16.67 %
cost of revenue
0.00 %
top top